Exact Sciences buy melinda
Start price
21.11.17
/
50%
€53.84
Target price
20.02.18
€56.83
Performance (%)
-18.80%
End price
20.02.18
€43.72
Summary
This prediction ended on 20.02.18 with a price of €43.72. The price of Exact Sciences has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.80%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Exact Sciences | - | - | - | - |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by melinda for this prediction
In the thread Exact Sciences diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 30/11 Präsentation
EXACT Sciences Corp. ist ein Molekulardiagnostik - Unternehmen , das sich auf die Früherkennung und Prävention von Krebs colorectal.Il geistigen Eigentums konzentriert , die seine molekulare Screening - Technologie zur nicht - invasiven Nachweis von Darmkrebs schützt
(Vom Mitglied beendet)
Stopped prediction by melinda for Exact Sciences
Exact Sciences
Start price
Target price
Perf. (%)
€102.74
12.06.19
12.06.19
€108.24
04.11.21
04.11.21
-16.12%
05.11.21
05.11.21
